Sunil Sharma M.D. Explains Possible New Drug to Treat Kidney Cancer

Published September 11, 2013

Sunil Sharma M.D. Explains Possible New Drug to Treat Kidney Cancer –

Phase 3 Data From The Medicines Company's Oritavancin Solo Trials Featured …

Filed under: drug treatment programs maryland

DENVER, CO–(Marketwired – Sep 10, 2013) – The Medicines Company (MDCO) today announced presentation of results for its Phase 3 SOLO clinical trial program of oritavancin at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy …
Read more on Investor’s Business Daily

Durata Therapeutics Presents New Pivotal Phase 3 Clinical Results and New In …

Filed under: drug treatment programs maryland

Dalbavancin is a novel antibacterial under investigation for the treatment of ABSSSI caused by susceptible Gram-positive microorganisms, such as Staphylococcus aureus (including MRSA and other multi-drug resistant strains) and Streptococcus pyogenes …
Read more on PipelineReview.com (press release)